MEI Pharma Company Profile (NASDAQ:MEIP)

About MEI Pharma

MEI Pharma logoMEI Pharma, Inc. is an oncology company. The Company is focused on the clinical development of drugs and therapies for treatment of cancer. The Company's portfolio of clinical drug candidates includes Pracinostat, ME-344 and PWT143. Pracinostat is an orally available histone deacetylase (HDAC) inhibitor indicated for the treatment of advanced hematologic diseases, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). ME-344 is an isoflavone-based mitochondrial inhibitor targeting a mitochondrial component of the terminal respiratory chain complex in rapidly proliferating cells. PWT143 is an oral inhibitor of phosphatidylinositide 3-kinase (PI3K) delta, a molecular target that plays a critical role in the proliferation and survival of hematologic cancer cells. Pracinostat has been tested in multiple Phase I and Phase II clinical trials in advanced hematologic malignancies and solid tumor indications.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MEIP
  • CUSIP:
Key Metrics:
  • Previous Close: $1.74
  • 50 Day Moving Average: $1.86
  • 200 Day Moving Average: $1.51
  • 52-Week Range: $0.87 - $2.28
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.00
  • P/E Growth: 40.20
  • Market Cap: $63.98M
  • Outstanding Shares: 36,772,000
  • Beta: 0.57
Profitability:
  • Return on Equity: -42.55%
  • Return on Assets: -39.33%
Debt:
  • Current Ratio: 8.48%
  • Quick Ratio: 8.48%
Additional Links:
Companies Related to MEI Pharma:

Analyst Ratings

Consensus Ratings for MEI Pharma (NASDAQ:MEIP) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $2.00 (14.94% upside)

Analysts' Ratings History for MEI Pharma (NASDAQ:MEIP)
Show:
DateFirmActionRatingPrice TargetDetails
8/2/2016WedbushReiterated RatingNeutral$2.00View Rating Details
10/7/2015Cowen and CompanyReiterated RatingBuyView Rating Details
9/2/2015Cantor FitzgeraldReiterated RatingBuyView Rating Details
3/24/2015Bank of America Corp.DowngradeBuy -> NeutralView Rating Details
3/24/2015Wells Fargo & Co.DowngradeOutperform -> Market Perform$2.25 -> $2.00View Rating Details
3/23/2015Stifel NicolausDowngradeBuy -> HoldView Rating Details
3/23/2015Roth CapitalDowngradeBuy -> Neutral$14.00 -> $2.50View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for MEI Pharma (NASDAQ:MEIP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/6/2016        
9/6/2016($0.20)($0.17)ViewN/AView Earnings Details
9/2/2015($0.23)($0.17)ViewN/AView Earnings Details
9/10/2014($0.37)($0.40)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for MEI Pharma (NASDAQ:MEIP)
Current Year EPS Consensus Estimate: $-0.57 EPS
Next Year EPS Consensus Estimate: $-0.58 EPS

Dividends

Dividend History for MEI Pharma (NASDAQ:MEIP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for MEI Pharma (NASDAQ:MEIP)
Insider Ownership Percentage: 3.14%
Institutional Ownership Percentage: 20.75%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/9/2015Vivo Ventures Vii, LlcMajor ShareholderSell390,572$1.84$718,652.48View SEC Filing  
1/21/2015Charles V Baltic IIIDirectorBuy5,000$3.81$19,050.00View SEC Filing  
12/9/2014Leaf Ventures Ii L.P. NewMajor ShareholderSell79,085$6.01$475,300.85View SEC Filing  
12/8/2014Leaf Ventures Ii L.P. NewMajor ShareholderSell9,004$6.05$54,474.20View SEC Filing  
6/30/2014Charles V Baltic IIIDirectorBuy2,000$6.56$13,120.00View SEC Filing  
10/29/2013Vivo Ventures Vii, LlcMajor ShareholderSell299,609$8.21$2,459,789.89View SEC Filing  
10/2/2013Vivo Ventures Vii, LlcMajor ShareholderSell581,646$10.16$5,909,523.36View SEC Filing  
8/16/2013Charles V Baltic IIIDirectorBuy2,600$6.82$17,732.00View SEC Filing  
6/28/2013Vivo Ventures Vii, LlcMajor ShareholderSell7,337$7.58$55,614.46View SEC Filing  
6/11/2013Vivo Ventures V, LlcMajor ShareholderSell13,727$7.80$107,070.60View SEC Filing  
5/16/2013Vivo Ventures Vii, LlcMajor ShareholderSell17,428$9.07$158,071.96View SEC Filing  
5/8/2013Leaf Ventures Ii L.P. NewMajor ShareholderSell200,000$8.58$1,716,000.00View SEC Filing  
1/25/2013Charles V Baltic IIIDirectorBuy10,200$6.04$61,608.00View SEC Filing  
12/21/2012Charles V Baltic IIIDirectorBuy3,500$7.18$25,130.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for MEI Pharma (NASDAQ:MEIP)
DateHeadline
News IconUnder the Microscope, Zeroing in at MEI Pharma, Inc. (NASDAQ:MEIP) - Duncan Research (NASDAQ:MEIP)
www.duncanindependent.com - September 23 at 10:48 AM
News IconPenny Stock Investors Keen on Shares of MEI Pharma, Inc. (NASDAQ:MEIP) - Duncan Research (NASDAQ:MEIP)
www.duncanindependent.com - September 22 at 10:53 AM
capitalcube.com logoMEI Pharma, Inc. :MEIP-US: Earnings Analysis: Q4, 2016 By the Numbers : September 21, 2016 (NASDAQ:MEIP)
www.capitalcube.com - September 21 at 5:48 PM
News IconStock Update, a Closer Look at MEI Pharma, Inc. (NASDAQ:MEIP) - Duncan Research (NASDAQ:MEIP)
www.duncanindependent.com - September 16 at 5:55 PM
News IconKeen Investors Seek Information on MEI Pharma, Inc. (NASDAQ:MEIP) - Duncan Research (NASDAQ:MEIP)
www.duncanindependent.com - September 16 at 5:55 PM
investornewswire.com logoCan Shares Of MEI Pharma, Inc. (NASDAQ:MEIP) Hit $2.5 - Investor Newswire (NASDAQ:MEIP)
www.investornewswire.com - September 14 at 10:22 AM
News IconBroker Buy/Sell/Hold Updates For MEI Pharma, Inc. (MEIP) - National Daily Press (NASDAQ:MEIP)
www.nationaldailypress.com - September 14 at 10:22 AM
News IconPenny Stock Investors Highly Curious in Shares of MEI Pharma, Inc. (NASDAQ:MEIP) - Duncan Research (NASDAQ:MEIP)
www.duncanindependent.com - September 13 at 10:56 AM
News IconMEI Pharma, Inc. (NASDAQ:MEIP) From The Analysts Point of View - National Daily Press (NASDAQ:MEIP)
www.nationaldailypress.com - September 9 at 10:50 AM
smarteranalyst.com logoCompany Update (NASDAQ:MEIP): MEI Pharma Inc Reports Fiscal Year 2016 Results - Smarter Analyst (NASDAQ:MEIP)
www.smarteranalyst.com - September 6 at 6:09 PM
publicnow.com logoMEI Pharma Reports Fiscal Year 2016 Results (NASDAQ:MEIP)
www.publicnow.com - September 6 at 10:51 AM
biz.yahoo.com logoMEI PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:MEIP)
biz.yahoo.com - September 2 at 3:25 PM
investornewswire.com logoMEI Pharma, Inc. (NASDAQ:MEIP) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:MEIP)
www.investornewswire.com - August 23 at 6:20 PM
biz.yahoo.com logoMEI PHARMA, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities (NASDAQ:MEIP)
biz.yahoo.com - August 17 at 6:19 PM
investornewswire.com logoWill MEI Pharma, Inc. (NASDAQ:MEIP) Hit $2 Price Target? - Investor Newswire (NASDAQ:MEIP)
www.investornewswire.com - August 16 at 6:13 PM
marketwatch.com logoMEI Pharma shares jump 51% in pre-market trade after $20 mln drug deal - MarketWatch (NASDAQ:MEIP)
www.marketwatch.com - August 10 at 6:32 PM
News IconMEI Pharma Inc (NASDAQ:MEIP) & Sunstone Hotel Investors (NYSE:SHO) Stocks to Watch - Money News (press release) (NASDAQ:MEIP)
www.newsismoney.com - August 10 at 6:32 PM
finance.yahoo.com logoMEI Pharma to Present at Wedbush PacGrow Healthcare Conference (NASDAQ:MEIP)
finance.yahoo.com - August 10 at 9:07 AM
News IconHelsinn partners with MEI Pharma to develop Pracinostat cancer drug (NASDAQ:MEIP)
myhealthbowl.com - August 9 at 6:22 PM
biz.yahoo.com logoMEI PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements a (NASDAQ:MEIP)
biz.yahoo.com - August 9 at 9:15 AM
stockhouse.com logoMid-Morning Market Update: Markets Edge Lower; Tyson Foods Tops Q3 Expectations (NASDAQ:MEIP)
www.stockhouse.com - August 8 at 10:49 AM
finance.yahoo.com logoHelsinn Group and MEI Pharma Enter Strategic Agreement for the Development and Commercialization of Pracinostat … (NASDAQ:MEIP)
finance.yahoo.com - August 8 at 10:49 AM
streetinsider.com logoMEI Pharma (MEIP), Helsinn Enter Development and Commercialization Agreement for Pracinostat (NASDAQ:MEIP)
www.streetinsider.com - August 8 at 10:49 AM
publicnow.com logoHelsinn Group and MEI Pharma Enter Strategic Agreement for the Development and Commercialization of Pracinostat for the Treatment of Acute Myeloid Leukemia and Other Hematologic Diseases (NASDAQ:MEIP)
www.publicnow.com - August 8 at 10:49 AM
marketwatch.com logoMEI Pharma shares jump 51% in pre-market trade after $20 mln drug deal (NASDAQ:MEIP)
www.marketwatch.com - August 8 at 10:49 AM
News IconHealthcare Stocks Gaining Limelight- CytRx Corporation (NASDAQ:CYTR), MEI Pharma (NASDAQ:MEIP) - Seneca Globe (NASDAQ:MEIP)
www.senecaglobe.com - August 4 at 6:29 PM
smarteranalyst.com logoWedbush Top Analyst Remains Sidelined on MEI Pharma Inc (MEIP) Despite Receiving Breakthrough Therapy ... - Smarter Analyst (NASDAQ:MEIP)
www.smarteranalyst.com - August 4 at 6:29 PM
smarteranalyst.com logoWedbush Top Analyst Remains Sidelined on MEI Pharma Inc (MEIP) Despite Receiving Breakthrough Therapy Designation; Here’s Why (NASDAQ:MEIP)
www.smarteranalyst.com - August 3 at 6:29 PM
News IconActive Stocks Notes Wondering in Hotspot- MEI Pharma, Inc. (NASDAQ:MEIP), Texas Roadhouse, Inc. (NASDAQ ... - Seneca Globe (NASDAQ:MEIP)
www.senecaglobe.com - August 2 at 6:26 PM
News IconSymantec Corporation (NASDAQ:SYMC) & MEI Pharma Inc (NASDAQ:MEIP) Stocks in Focus - Money News (press release) (NASDAQ:MEIP)
www.newsismoney.com - August 2 at 6:26 PM
streetinsider.com logoMEI Pharma's (MEIP) Pracinostat Receives FDA Breakthrough Therapy Designation - StreetInsider.com (NASDAQ:MEIP)
www.streetinsider.com - August 1 at 10:50 AM
publicnow.com logoMEI Pharma's Pracinostat Receives Breakthrough Therapy Designation from FDA for Treatment in Combination with Azacitidine of Patients with Newly Diagnosed Acute Myeloid Leukemia Unfit for Intensive Chemotherapy (NASDAQ:MEIP)
www.publicnow.com - August 1 at 8:51 AM
finance.yahoo.com logo8:33 am MEI Pharma announces the FDA has granted Breakthrough Therapy Designation for the investigational drug Pracinostat in combination with azacitidine for the treatment of acute myeloid leukemia (NASDAQ:MEIP)
finance.yahoo.com - August 1 at 8:33 AM
investornewswire.com logoCan Shares Of MEI Pharma, Inc. (NASDAQ:MEIP) Hit $2? - Investor Newswire (NASDAQ:MEIP)
www.investornewswire.com - July 28 at 9:22 AM
News IconTracking Analyst Ratings and Target Projections for: MEI Pharma, Inc. (NASDAQ:MEIP) - Press Telegraph (NASDAQ:MEIP)
presstelegraph.com - July 21 at 6:24 PM
fiscalstandard.com logoBroker Outlook For MEI Pharma, Inc. (MEIP) - Fiscal Standard (NASDAQ:MEIP)
www.fiscalstandard.com - July 21 at 6:24 PM
News IconTrading Performance and Target Watch for MEI Pharma, Inc. (NASDAQ:MEIP) - Press Telegraph (NASDAQ:MEIP)
presstelegraph.com - July 19 at 11:59 AM
News IconMEI Pharma, Inc. (NASDAQ:MEIP): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:MEIP)
www.engelwooddaily.com - July 19 at 11:59 AM
News IconShares Moving Down on the Week: MEI Pharma, Inc. (NASDAQ:MEIP) - Engelwood Daily (NASDAQ:MEIP)
www.engelwooddaily.com - July 17 at 10:27 AM
News IconShares Experiencing a Downtrend: MEI Pharma, Inc. (NASDAQ:MEIP) - TGP (NASDAQ:MEIP)
telanaganapress.com - July 16 at 9:29 AM
News IconStock Volatility Focus for: MEI Pharma, Inc. (NASDAQ:MEIP) - Engelwood Daily (NASDAQ:MEIP)
www.engelwooddaily.com - July 12 at 6:24 PM
ftsenews.co.uk logoMEI Pharma, Inc. (MEIP) Updated Price Targets - FTSE News (NASDAQ:MEIP)
www.ftsenews.co.uk - July 12 at 6:24 PM
investornewswire.com logoStrong Sell Calls For MEI Pharma, Inc. (NASDAQ:MEIP) At 0 - Investor Newswire (NASDAQ:MEIP)
www.investornewswire.com - July 12 at 6:24 PM
fiscalstandard.com logoMEI Pharma, Inc. (MEIP) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:MEIP)
www.fiscalstandard.com - July 10 at 10:22 AM
investornewswire.com logoMEI Pharma, Inc. (NASDAQ:MEIP) Expected to Reach Highs Of $2 - Investor Newswire (NASDAQ:MEIP)
www.investornewswire.com - July 7 at 6:11 PM
News IconMEI Pharma, Inc. (NASDAQ:MEIP) Company Rating and Target Watch - Telanagana Press (NASDAQ:MEIP)
telanaganapress.com - July 1 at 6:08 PM
fiscalstandard.com logoRecently Issued Stock Ratings For MEI Pharma, Inc. (MEIP) - Fiscal Standard (NASDAQ:MEIP)
www.fiscalstandard.com - July 1 at 6:08 PM
News IconShare Update and Earnings Review for MEI Pharma, Inc. (NASDAQ:MEIP) - Press Telegraph (NASDAQ:MEIP)
presstelegraph.com - June 28 at 10:59 AM
News IconMEI Pharma, Inc. (NASDAQ:MEIP) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:MEIP)
www.engelwooddaily.com - June 28 at 10:59 AM
News IconEquity Research and Technical Review on MEI Pharma, Inc. (NASDAQ:MEIP) - Press Telegraph (NASDAQ:MEIP)
presstelegraph.com - June 28 at 10:59 AM

Social

MEI Pharma (NASDAQ:MEIP) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff